Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 360 of 5804
-
New pill may help adults with rare adrenal disorder cut back on steroids
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy, safety, PK, and PD of atumelnant in adults with classic CAH due to 21-OHD.
Phase: PHASE3 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New pill combo aims to slash cholesterol in High-Risk patients
Disease control Recruiting nowThis study will be a placebo-controlled, double-blind, randomized, Phase 3 study to evaluate the efficacy, safety, and tolerability of obicetrapib 10 mg, both as a fixed-dose combination (FDC) with ezetimibe 10 mg and as monotherapy, on top of guideline-recommended lipid-lowering…
Phase: PHASE3 • Sponsor: NewAmsterdam Pharma • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug tofersen under watch for ALS patients in china
Disease control Recruiting nowIn this study, researchers will learn more about the safety of tofersen, also known as Qalsody®. This is a drug available for doctors to prescribe for people with a certain type of amyotrophic lateral sclerosis, also known as ALS. This type is in people who have a mutation in the…
Phase: PHASE4 • Sponsor: Biogen • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Promising combo targets rare blood cancer in early trial
Disease control Recruiting nowThe goal of this clinical trial is to study the efficacy of the tagraxofusp + venetoclax combination in treatment-naive blastic plasmacytoid dendritic cell neoplasm adult patients. The main question is to verify the response in patients after 3 cycles of tagraxofusp+venetolax an…
Phase: PHASE2 • Sponsor: French Innovative Leukemia Organisation • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug combo targets stomach cancer protein in 100-Patient trial
Disease control Recruiting nowThis study examines whether adding the drug Zolbetuximab to an existing treatment (Paclitaxel and Ramucirumab) can improve patients' survival. The goal is to see if this combination works better for patients whose tumours contain a specific protein (CLDN18.2). The results will be…
Phase: PHASE2 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
AI face scan could spot hidden heart disease
Diagnosis Recruiting nowThis study aims to evaluate the effectiveness of this facial image-based AI algorithm for screening CAD in high-risk community populations (specifically individuals with diabetes, hypertension, or aged over 65). The main objectives are: 1. To verify if the AI algorithm can accur…
Sponsor: China National Center for Cardiovascular Diseases • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC
-
Robot vs. sonographer: 70,000 women join breast cancer screening showdown
Diagnosis Recruiting nowThe goal of this clinical trial is to learn if robotic ultrasound screening works as well as or better than traditional sonographer-led screening for detecting breast cancer. It will also explore how well participants follow recommended post-screening care. The main questions it …
Phase: NA • Sponsor: Huazhong University of Science and Technology • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC
-
New blood test could spot breast cancer earlier
Diagnosis Not yet recruitingPrimary Objective: 1\. To evaluate the sensitivity of the SpotitEarly test for breast cancer detection in women Secondary Objectives: 1. To evaluate the performance of the SpotitEarly in various subgroups. 2. To evaluate the performance of the SpotitEarly test in detecting ear…
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Diagnosis
Last updated Apr 28, 2026 13:01 UTC
-
Could a gut bacteria transplant save lungs from sepsis?
Disease control Recruiting nowSepsis is a systemic inflammatory response syndrome triggered by infection, and it is a common critical illness in clinical practice, often leading to multiple organ dysfunction. Among these, acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are among the mos…
Phase: PHASE2, PHASE3 • Sponsor: Shanghai University of Traditional Chinese Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Could melatonin help save Babies' brains after birth injury?
Disease control OngoingTo compare the survival rate and improvement in stage of hypoxic ischemic encephalopathy (HIE) at day 7 of treatment in neonates treated with versus without melatonin in addition to standard supportive therapy.
Phase: PHASE2 • Sponsor: University of Child Health Sciences and Children's Hospital, Lahore • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Can community coalitions slash HIV rates in the south?
Prevention ENROLLING_BY_INVITATIONThis study will evaluate a status-neutral integrated strategy to improve access to and uptake of HIV prevention and treatment services for the highest HIV incidence (HHI) men who have sex with men (MSM) in participating communities. The ultimate goal is to establish a strategy to…
Phase: NA • Sponsor: HIV Prevention Trials Network • Aim: Prevention
Last updated Jun 27, 2026 11:01 UTC
-
Engineered immune cells take on lupus in early trial
Disease control Not yet recruitingThe purpose of this clinical trial is to learn if CD19/BCMA CAR-T works to treat refractory SLE in adults. It will also learn about the safety and efficacy of the CD19/BCMA CAR-T cell product. The main questions it aims to answer are: 1. What CAR-T-related adverse events (AEs) …
Phase: EARLY_PHASE1 • Sponsor: Chengdu Ucello Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New drug cocktail aims to spare bladders in tough cancer
Disease control Not yet recruitingThis is a prospective, open-label, single-center, single-arm clinical study. Plans to enroll 45 MIBC patients with clinical stage T2-T4aN0M0 and HER2-positive (IHC 1+/2+/3+) status. Treatment Flow: Post maximal Transurethral Resection of Bladder Tumor (TURBT); 2 cycles of Gemcita…
Phase: PHASE2 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New drug combo aims to fight advanced ovarian cancer before surgery
Disease control Recruiting nowA Phase 1B/2 Study to Investigate the Safety and Efficacy of TORL-1-23 with Chemotherapy Given Before Initial Surgery in Women with Advanced Stage Ovarian Cancer
Phase: PHASE1, PHASE2 • Sponsor: TORL Biotherapeutics, LLC • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Promising new drug cocktail targets tough pancreatic cancer
Disease control Not yet recruitingThis is a prospective, multicenter, randomized, double-blind, placebo-controlled study. Led by The First Affiliated Hospital with Nanjing Medical University and Peking University Cancer Hospital \& Institute (as leading centers), its main purpose is to evaluate the clinical effic…
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Fly-fighting paint and larvicide aim to slash diarrhoea in south sudan camps
Prevention Not yet recruitingObjectives The main trial objective is to evaluate the efficacy of insecticidal paint (PAINT) or larvicide (LARV), or both interventions combined, on filth fly density and hence transmission of diarrhoeal diseases. Primary Objective • To evaluate the efficacy of PAINT or LARV, …
Phase: PHASE3 • Sponsor: The Mentor Initiative • Aim: Prevention
Last updated Jun 27, 2026 08:03 UTC
-
New combo therapy aims to outsmart resistant breast cancer
Disease control Recruiting nowThe Substudy Protocol ASPEN-09-03 is a Phase 2, single-arm, multicenter study evaluating the efficacy, safety, and tolerability of evorpacept in combination with trastuzumab and chemotherapy in participants with HER2-positive metastatic breast cancer who have previously received …
Phase: PHASE2 • Sponsor: ALX Oncology Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New hope for lung cancer patients whose treatment has failed
Disease control Recruiting nowNon-small cell lung cancer (NSCLC) is a common type of lung cancer where abnormal cells in the lungs grow out of control. The purpose of this study is to assess adverse events and change in disease activity of telisotuzumab adizutecan as a monotherapy or in combination with osime…
Phase: PHASE2, PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New drug cocktail targets tough lung cancer
Disease control Not yet recruitingThis is an open-label, multicenter, Phase II clinical study designed to evaluate the safety and efficacy of JSKN033 in the treatment of patients with advanced NSCLC. The study is divided into two phases: Part 1 (Dose Selection) and Part 2 (Cohort Expansion). Enrolled subjects are…
Phase: PHASE2 • Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New drug combo takes on tough lung cancer
Disease control Recruiting nowThis study is being done to learn more about a new medicine called PF-08634404 and how well it works when given with chemotherapy to adults with extensive-stage small cell lung cancer (ES-SCLC), a fast-growing type of lung cancer that has spread widely in the body. To join the s…
Phase: PHASE2, PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC